What does the Global Mammography Horizon report cover?

The report covers the global mammography market and broader breast imaging ecosystem from 2024A to 2035F. It includes dedicated mammography systems, FFDM, digital breast tomosynthesis, contrast-enhanced mammography, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathways, breast ultrasound, and breast MRI adjacencies.

Which companies are discussed in the report?

The report discusses systems OEMs, AI vendors, workflow platforms, interventional breast pathway companies, provider networks, mobile access models, China/value-tier challengers, detector suppliers, and CEM/photon-counting enabling-stack companies. Examples include Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, United Imaging, Wandong, ScreenPoint, Lunit/Volpara, RadNet/DeepHealth/iCAD, Visage/Pro Medicus, Sectra, Mammotome, BD, Merit Medical, Varex, Bayer, Bracco, and Guerbet.

What is the Core Mammography Market?

The Core Mammography Market includes dedicated mammography systems, mammography-specific service contracts, mammography-specific software and workstations, and mammography AI/workflow revenue. It does not blend in breast biopsy, breast ultrasound, or breast MRI without explicit bridge labeling.

How does the report treat AI revenue?

The report separates vendor-net AI/workflow revenue from provider-gross AI economics. Vendor-net revenue refers to software revenue booked by vendors, OEMs, or workflow platforms. Provider-gross economics include productivity, patient-pay, reimbursement, recall management, and downstream workflow value captured by providers.

How is this report different from a standard mammography equipment market report?

A standard equipment report often focuses on unit shipments, installed base, ASPs, and system revenue. This Horizon report adds market-structure analysis, AI monetization, CEM strategy, interventional breast pathway economics, breast US/MRI adjacencies, regional archetypes, competitive control planes, and strategic frameworks for commercial decision-making.

Who should buy this report?

This report is designed for medical imaging OEMs, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, biopsy and interventional breast companies, detector and contrast suppliers, provider networks, investors, private equity, distributors, and public-sector screening or procurement stakeholders.

Company News – Marketstrat

Marketstrat Receives USPTO Registration for Markintel® Service Mark

Registration reinforces Marketstrat’s commitment to building a structured market intelligence…

Marketstrat Releases ‘Global Ultrasound Horizon: Market Structure, Forecasts, and AI Monetization Architecture’ Report

New Markintel™ Horizon report maps the global ultrasound ecosystem from…

Marketstrat Releases ‘Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A-2035E)’ Report

New Markintel Horizon report maps the global MRI ecosystem from…

Marketstrat Releases ‘World Market for Oncology Imaging AI 2023–2032’ Horizon Report

Marketstrat Launches Markintel™ Methodology & Frameworks to Transform Data Overload into Actionable Intelligence for MedTech, Healthcare, and Other Complex Sectors

Apr 2, 2025 Marketstrat™, a specialized market intelligence and GTM…

Marketstrat Reintroduces itself with a Fresh Look and an AI-Focused Vision

Jan 2025 We’re thrilled to announce Marketstrat’s renewed direction—complete with…

Company News

Marketstrat Receives USPTO Registration for Markintel® Service Mark

Marketstrat Releases ‘Global Ultrasound Horizon: Market Structure, Forecasts, and AI Monetization Architecture’ Report

Marketstrat Releases ‘Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A-2035E)’ Report

Marketstrat Releases ‘World Market for Oncology Imaging AI 2023–2032’ Horizon Report

Marketstrat® Trademark Registered by USPTO

Marketstrat Releases “World Market for AI in Medical Imaging 2025–2032,” Mapping a US$2.7B Market to US$28.4B by 2032

Marketstrat Launches Markintel™ Methodology & Frameworks to Transform Data Overload into Actionable Intelligence for MedTech, Healthcare, and Other Complex Sectors

Marketstrat Reintroduces itself with a Fresh Look and an AI-Focused Vision

Quick Links

Solutions

Contact us